Skip to content
MedsAcross

Brand family

Remodulin

Treprostinil · United Therapeutics
United States
Presentations
5
Markets
1

Remodulin is a brand of Treprostinil marketed by United Therapeutics, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Treprostinil
Brand owner
United Therapeutics
Registered in
United States
Strengths and forms
100 mg/20 mL injection, 20 mg/20 mL injection, 200 mg/20 mL injection, 50 mg/20 mL injection, 8 mg/20 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Remodulin 100 mg/20 mL injectionIntravenous, subcutaneousUnited TherapeuticsUS FDAAvailable on request
Remodulin 20 mg/20 mL injectionIntravenous, subcutaneousUnited TherapeuticsUS FDAAvailable on request
Remodulin 200 mg/20 mL injectionIntravenous, subcutaneousUnited TherapeuticsUS FDAAvailable on request
Remodulin 50 mg/20 mL injectionIntravenous, subcutaneousUnited TherapeuticsUS FDAAvailable on request
Remodulin 8 mg/20 mL injectionIntravenous, subcutaneousUnited TherapeuticsUS FDAAvailable on request

Equivalent brands

Other brands of Treprostinil.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Remodulin

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.